SERUM ALPHA(1)-ANTITRYPSIN AND ALPHA(2)-MACROGLOBULIN IN ALZHEIMERS AND BINSWANGERS-DISEASE

Citation
T. Wetterling et Kf. Tegtmeyer, SERUM ALPHA(1)-ANTITRYPSIN AND ALPHA(2)-MACROGLOBULIN IN ALZHEIMERS AND BINSWANGERS-DISEASE, The Clinical investigator, 72(3), 1994, pp. 196-199
Citations number
19
Categorie Soggetti
Medicine, General & Internal
Journal title
ISSN journal
09410198
Volume
72
Issue
3
Year of publication
1994
Pages
196 - 199
Database
ISI
SICI code
0941-0198(1994)72:3<196:SAAAIA>2.0.ZU;2-#
Abstract
The deposition of beta(A4)-amyloid in senile plaques and small cerebra l vessels is one of the pathological hallmarks of Alzheimer's disease. Recent data suggest that protease inhibitors such as alpha(2)-macrogl obulin may be involved in the process of forming beta(A4) amyloid depo sits. Compared to 34 persons without neurological diseases, the serum content of alpha(1)-antitrypsin was increased in 16 patients with Alzh eimer's disease and 15 with Binswanger's disease. In the latter alpha( 2)-macroglobulin was also elevated in serum. Our results show no evide nce of a blood-borne origin of the protein or peptid deposited in the walls of small vessels in Alzheimer's or Binswanger's disease. Neverth eless, the elevated proteinase inhibitor concentrations may play a rol e in the pathogenesis of these diseases.